Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SeLan: CGM-based Prandial Insulin Adjustment in T2DM
NCT01234597Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2012
- Primary completion
- Apr 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2012; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01234597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01234597.